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Myelodysplastic syndromes (MDS) are hematological malignancies of unclear etiology where oxidative stress may
contribute to the pathogenesis. Methylarginines, naturally occurring inhibitors of NO synthase, can increase
superoxide generation from uncoupled NO synthase. We found significant increase in concentrations of asymmetric
dimethylarginine (0.84 ± 0.32 μmol/L, p = 0.0022) and malondialdehyde (0.77 ± 0.11 μmol/L, p < 0.001) in sera of
MDS patients vs controls (asymmetric dimethylarginine: 0.56 ± 0.16 μmol/L, malondialdehyde: 0.52 ± 0.07 μmol/L).
On the contrary, nitrites concentrations were significantly decreased in MDS patients (1.71 ± 0.46 μmol/L, p = 0.0028)
vs controls (2.16 ± 0.38 μmol/L). We suppose that the oxidative stress in MDS is enhanced due to methylated
arginines influence on NO synthase activity impairment.To the editor
Myelodysplastic syndromes (MDS) are a heterogeneous
group of clonal hematological disorders, characterized
by ineffective hematopoiesis and a high risk of trans-
formation into acute myeloid leukemia. It has been de-
termined that oxidative stress plays a role in the
initialization and disease progression [1]. The reactive
oxygen species may oxidize tetrahydrobiopterin resulting
into nitric oxide synthase (NOS) uncoupling and prefer-
ential formation to superoxide anion radical. It was
found that methylarginines (asymmetric dimethylar-
ginine - ADMA, NG-monomethyl-L-arginine - MMA
and symmetric dimethylarginine - SDMA), naturally oc-
curring inhibitors of NOS [2], can profoundly increase
superoxide generation from uncoupled NOS [3]. Free
methylated arginines, capable of inhibiting NOS [4], are
formed exclusively by the sequence of methylation of
arginine residues of proteins, followed by proteolysis
of these proteins. Protein arginine methylation is in
mammalian cells carried out by protein arginine* Correspondence: Jiri.Suttnar@uhkt.cz
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reproduction in any medium, provided the ormethyltransferases (PRMTs); many of them show links
to cancer [5].
The subjects of the study are characterized in Table 1.
Ethics approval (Ethics Committee of the Institute of
Hematology and Blood Transfusion) and informed con-
sent from all subjects were obtained. Serum concentra-
tion of oxidative stress marker malondialdehyde (MDA)
was estimated using liquid chromatography (Shimadzu,
Tokyo, Japan) of its thiobarbituric acid derivative [6].
Methylated arginines were analyzed using HILIC chro-
matography with MS/MS detection (ABSciex, Framing-
ham, USA) [7]. Nitrites were assayed by chromatography
using the fluorescent reaction product with 2,3-diamino-
naphthalene [8].
The concentrations of methylated arginine derivatives,
malondialdehyde and nitrites are summarized in the
Table 2. We found significantly increased serum concen-
trations of ADMA, SDMA, MMA, and MDA in sera of
MDS patients as compared with healthy donors. The ni-
trites concentrations were significantly decreased in seraal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Baseline characteristics of MDS patients and
healthy controls
MDS Controls
aAge (years) 43.7 (33–59) 44.3 (37–67)
Male/Female 11/9 8/8
aSerum iron [μmol/L] 22.3 (11.4-43.3) b8.5-28
aSerum ferritin [μg/L] 641.2 (8.9-1907.3) b15-150
aThe data are depicted as averages with ranges. bReference interval.
Table 2 Concentrations of methylated arginines in sera of
MDS patients and healthy controls
MDS Controls ap
ADMA [μmol/L] 0.84 ± 0.32 0.56 ± 0.16 0.0022**
SDMA [μmol/L] 0.54 ± 0.18 0.42 ± 0.14 0.0361*
MMA [μmol/L] 0.14 ± 0.05 0.10 ± 0.03 0.033*
Homoarginine [μmol/L] 1.77 ± 1.06 2.32 ± 1.26 0.1777
Citrulline [μmol/L] 46.68 ± 14.96 42.19 ± 12.31 0.3298
MDA [μmol/L] 0.77 ± 0.11 0.52 ± 0.07 <0.001***
Nitrites [μmol/L] 1.71 ± 0.46 2.16 ± 0.38 0.0028**
The data are represented as averages ± SD. ADMA, NG, NG-dimethyl-L-arginine;
MMA, NG-monomethyl-L-arginine; SDMA, NG,NG’-dimethyl-L-arginine; MDA,
malondialdehyde. aTwo-tailed t-test was used to compare measured
concentrations of analytes in MDS patients with healthy donors. Statistical
significance coding: * p < 0.05, ** p < 0.01 and *** p < 0.001.
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centration of ADMA strongly positively correlated with
concentration of MMA (r = 0.87, p < 0.001) and SDMA
(r = 0.70, p < 0.001). ADMA concentration moderately
positively correlated with MDA concentration (r = 0.50,
p = 0.006).
Our results showed significantly increased oxidative
stress even in MDS patients characterized by moderately
enhanced iron and serum transferrin concentrations.
Resulting shift of overexpressed [9] NO synthase activity
in favour of superoxide production at the expense of ni-
tric oxide synthesis (reflected by nitrites concentrations
[10]) was further augmented at the presence of meth-
ylated arginines. Therefore, oxidative stress in MDS
patients could be explained by a positive feedback of
both superoxide and methylated arginines on original
NOS activity impairment. Moreover, recently pro-
posed PRMT-specific inhibitors [11] might have a
therapeutic effect on leukemia also by oxidative stress
reduction.Abbreviations
MDS: Myelodysplastic syndromes; NOS: Nitric oxide synthase; ADMA: NG,
NG-dimethyl-L-arginine; MMA: NG-monomethyl-L-arginine; SDMA: NG,
NG’-dimethyl-L-arginine; MDA: Malondialdehyde; PRMT: protein arginine
methyltransferase.
Competing interest
The authors indicated no potential conflicts of interest.
Authors’ contributions
JŠ performed LC-MS/MS analysis of methylated derivatives of arginine.
JS participated on LC-MS/MS analysis of methylated derivatives of arginine,
carried out data analysis and interpretation and wrote the manuscript.
KP and LCM performed malondialdehyde and nitrite analysis. JČ provided
clinical data and patient samples. JED conceived of the study and wrote the
manuscript. Final approval of the manuscript: All the co-authors. All authors
read and approved the final manuscript.
Acknowledgement
This work was supported by Grant CZ.2.16/3.1.00/24001 of the EU ERDF
OPPK, by P205/12/G118 of Centrum Excellence, by Grant KAN200670701
from the Academy of Sciences, Czech Republic and by the Ministry of
Health, Czech Republic project for the conceptual development of research
organization, VZ MZ 00002373601 IHBT.
Received: 17 July 2013 Accepted: 17 August 2013
Published: 19 August 2013
References
1. Farquhar MJ, Bowen DT: Oxidative stress and the myelodysplastic
syndromes. Int J Hematol 2003, 77:342–350.
2. Leiper J, Vallance P: Biological significance of endogenous
methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999,
43:542–548.
3. Druhan LJ, Forbes SP, Pope AJ, Chen CA, Zweier JL, Cardounel AJ:
Regulation of eNOS-derived superoxide by endogenous methylarginines.
Biochemistry 2008, 47:7256–7263.
4. Teerlink T: ADMA metabolism and clearance. Vasc Med 2005, 10:S73–S81.
5. Yang Y, Bedford MT: Protein arginine methyltransferases and cancer.
Nat Rev Cancer 2013, 13:37–50.
6. Suttnar J, Masova L, Dyr JE: Influence of citrate and EDTA anticoagulants
on plasma malondialdehyde concentrations estimated by high-
performance liquid chromatography. J Chromatogr B Biomed Sci Appl
2001, 751:193–197.
7. Martens-Lobenhoffer J, Bode-Boger SM: Fast and Efficient Determination
of Arginine, Symmetric Dimethylarginine, and Asymmetric
Dimethylarginine in Biological Fluids by Hydrophilic-Interaction Liquid
Chromatography– Electrospray Tandem Mass Spectrometry. Clin Chem
2006, 52:3488–3493.
8. Li H, Meininger CJ, Wu G: Rapid determination of nitrite by reversed-
phase high-performance liquid chromatography with fluorescence
detection. J Chromatogr B Biomed Sci Appl 2000, 746:199–207.
9. Kitagawa M, Takahashi M, Yamaguchi S, Inoue M, Ogawa S, Hirokawa K,
Kamiyama R: Expression of inducible nitric oxide synthase (NOS) in
bone marrow cells of myelodysplastic syndromes. Leukemia 1999,
13:699–703.
10. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, Kelm M:
Plasma nitrite rather than nitrate reflects regional endothelial nitric
oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl
Acad Sci U S A 2001, 98:12814–12819.
11. Copeland RA, Solomon ME, Richon VM: Protein methyltransferases as a
target class for drug discovery. Nat Rev Drug Discov 2009, 8:724–732.
doi:10.1186/1756-8722-6-58
Cite this article as: Štikarová et al.: Enhanced levels of asymmetric
dimethylarginine in a serum of middle age patients with
myelodysplastic syndrome. Journal of Hematology & Oncology 2013 6:58.
